Answers are grounded in this paper and cite their sources.
In the treatment of inflammatory eye diseases, the ophthalmologist often has to face a difficult choice of pharmacological treatment strategies. It is worth remembering that the available ophthalmic drugs may differ substantially from one another, hence it is important to take into account the pharmacokinetic- pharmacodynamic profile of the drugs used. Different mechanisms of action as well as different tolerance of topically applied drugs can affect both the effectiveness and safety of the treatment.
No takes yet. Share an insight, caveat, or question.
Jarosław Woroń (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: